Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Medibank Private ( (AU:MPL) ) is now available.
Medibank has announced a change in the recording of director David Koczkar’s interests in company securities, clarifying that while the entities through which his holdings are held have changed, the total number of Medibank securities in which he has a direct and indirect interest remains unchanged from the disclosure lodged on 19 December 2025. The update is a technical adjustment to the register of interests rather than a change in Koczkar’s overall economic exposure to Medibank, and reflects the company’s ongoing compliance with ASX disclosure requirements and corporate governance obligations, with no direct operational or strategic impact indicated for shareholders or other stakeholders.
The most recent analyst rating on (AU:MPL) stock is a Hold with a A$5.05 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.
More about Medibank Private
Medibank Private Limited is a leading Australian private health insurer, providing health insurance products and related services to individuals and businesses across the country. The company operates in the broader healthcare and insurance industry, focusing on health cover, health services, and supporting policyholders’ access to medical care within Australia’s mixed public-private health system.
YTD Price Performance: 30.83%
Average Trading Volume: 5,863,242
Technical Sentiment Signal: Buy
Current Market Cap: A$13.14B
For an in-depth examination of MPL stock, go to TipRanks’ Overview page.